Arteris, Inc. (AIP) | The Buildout — AI Infrastructure
The Verdict
Arteris supplies semiconductor system IP that chip designers license to move data across increasingly complex AI-era chips and chiplets. Its portfolio spans network-on-chip interconnect, SoC integration automation, and hardware security verification. That makes it a picks-and-shovels layer of the AI buildout: it does not build chips or data centers, but its IP sits inside the advanced processors, chiplets, and automotive systems those workloads depend on.
| Market Cap | — |
| Revenue (TTM) | $77M |
| Revenue Growth | +25.4% |
| EBITDA Margin (TTM) | -39.4% |
| Net Cash | $33M |
| Earnings Beats | 6 of 7 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- ACV plus royalties reached a record $99.5 million in Q2 2026, up 44% YoY.
- Remaining performance obligations hit an all-time high of $135 million; just over half is expected to be recognized in the next 12 months.
- Trailing 12-month royalties reached $8.6 million, up 65% YoY, and large royalty reporters grew from 1 to 3.
- No single customer was more than 10% of revenue in H1 2026, a diversification milestone.
- Cash and investments were $123 million with no financial debt after a $72 million ATM raise.
What We’re Watching
- Q4 2026 non-GAAP operating profit target remains unproven; Q3 is guided to a $3M-$1M loss, and the bridge to profitability is not quantified.
- Full-year non-GAAP operating loss guidance widened to $10M-$7M even as revenue guidance was raised.
- Government/security work is structurally lower-margin and pulled GAAP gross margin to 85% in Q2.
- CFO transition: Saurabh Sinha joins September 8, 2026 from EVA Technologies.
The demand side of the thesis is strengthening: records in ACV plus royalties, RPO, royalties, and design starts, with enterprise/AI leading the mix. The profitability side is weakening: the full-year operating loss guide widened even as revenue was raised, and the Q4 2026 profit target now requires an unexplained swing from a Q3 guided loss. The open question is whether the cost and mix drags are one-time or structural enough to push the profit inflection beyond Q4 2026.
Earnings Beat
Arteris reported Q2 2026 revenue of $24.1 million, up 46% year over year and above the top end of guidance. Non-GAAP gross margin was 87% and GAAP gross margin 85%. The quarter's standout demand indicators were ACV plus royalties of $99.5 million, up 44%, and RPO of $135 million.
| Metric | Q1 FY2026 | Q4 FY2025 | Q1 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $23M | $20M | $16M | +38.8% |
| Gross margin | 83.0% | 90.8% | 90.8% | -780bps |
| EBITDA | −$7M | −$8M | −$7M | +7.2% |
| EPS | $-0.18 | $-0.19 | $-0.20 | −11.2% |
| ACV plus royalties | $99.5M | $92.8M | n/a | +44% YoY |
| Remaining performance obligations | $135M | $118M | n/a | record; YoY not disclosed |
the upward trajectory is slightly slower— Nick Hawkins, CFO, 2026-08-06
Management tone: Management's tone remained confident, direct, and candid. CFO Nick Hawkins specifically acknowledged the Q2 operating loss miss and the widened full-year loss guide, attributing them to French RSU payroll taxes, government/security mix, and higher commissions.
Management Guidance
Q3 2026 guidance was initiated at revenue of $24M-$25M, ACV plus royalties of $99M-$103M, and a non-GAAP operating loss of $3M-$1M. FY2026 guidance was updated to revenue of $95M-$98M, ACV plus royalties exit of $102M-$106M, non-GAAP operating loss of $10M-$7M, and positive non-GAAP free cash flow of $5M-$9M. Quarterly free cash flow guidance was no longer provided.
Trajectory
Revenue is accelerating: Q1 FY2026 grew 39% YoY and Q2 2026 grew 46% to $24.1 million. The driver is a mix of new and expanded licenses, rising royalties, and the new Cycuity hardware security verification business. Gross margin is compressing as lower-margin government/security subcontractor work enters cost of revenue; Q2 2026 GAAP gross margin was 85%, down from roughly 90% a year earlier.
The Model
The model projects FY+1 revenue of $99 million with negative EBITDA of $23 million (-23.0% margin), improving to FY+2 revenue of $138.0 million with negative EBITDA of $10 million (-6.9% margin). The near-term anchor is the $95M-$98M FY2026 revenue guide and the recency of the Cycuity integration; FY+2 assumes the royalty and chiplet/multi-die pipeline begins converting at scale. The five-run dispersion shows an 11% spread in FY+2 revenue, from $128M at the low end to $143M at the high end.
| Metric | FY2025 | Next FY (E) | Following FY (E) |
|---|---|---|---|
| Revenue | $70M | $99M | $138M |
| YoY Growth | — | +40.4% | +39.4% |
| EBITDA | −$30M | −$23M | −$10M |
| EBITDA Margin | -42.3% | -23.0% | -6.9% |
Projections are the median of 5 independent model runs. The model’s revenue sits 21.9% above analyst consensus.
Q3 2026 guidance was initiated at revenue of $24M-$25M, ACV plus royalties of $99M-$103M, and a non-GAAP operating loss of $3M-$1M. FY2026 guidance was updated to revenue of $95M-$98M, ACV plus royalties exit of $102M-$106M, non-GAAP operating loss of $10M-$7M, and positive non-GAAP free cash flow of $5M-$9M. Quarterly free cash flow guidance was no longer provided.
What Could Go Right — and Wrong
- Hyperscaler standardization on Arteris infrastructure silicon converts into expanded licenses and visible multi-year revenue.
- The two chiplet/multi-die system IP products reach production during 2026, establishing Arteris in the next design architecture.
- Cycuity security cross-sell into the 200+ semiconductor design company base adds measurable ACV beyond government contracts.
- Royalty base broadens further; the TTM $8.6M stream, up 65%, continues to scale toward management's high-thirties-to-low-forties long-term growth.
- Non-GAAP operating profit arrives as early as Q4 2026 and validates the operating-leverage model.
- AI design starts or hyperscaler capex slow, with two-thirds of engagements tied to AI chips.
- Full-year non-GAAP operating loss widens again and the Q4 2026 profit target slips.
- Royalty lumpiness repeats: a single customer's logistics issue caused a Q2 sequential pause.
- Government/security mix structurally drags gross margin lower as it scales.
- CFO transition or Qualcomm FlexNoC license dependency introduces financial-policy or core-IP disruption.
Looking Ahead
The next 12 months center on the profitability inflection and product-cycle milestones. Management still targets non-GAAP operating profit as early as Q4 2026, but Q3 is guided to a $3M-$1M loss. During 2026 the company also expects two chiplet/multi-die system IP products to move into production, while the Cycuity security unit works to convert its 200+ design-company base and expand Arm adoption. The CFO transition on September 8, 2026 adds a governance checkpoint.
- Q3 2026Q3 2026 results — Tests guided $24M-$25M revenue and the bridge to the Q4 2026 non-GAAP operating profit target.
- September 8, 2026New CFO joins — Saurabh Sinha starts from EVA Technologies; tests guidance and capital-allocation continuity.
- Q4 2026Non-GAAP operating profit target — First possible quarter for operating profit; bridge from Q3 loss not quantified.
- During 2026Chiplet/multi-die IP products — Two early-adopter products targeted to reach production for AI, HPC, ADAS.
- OngoingCycuity/Arm security expansion — Arm adoption across next-generation processors; security cross-sell to 200+ customers.
Financials
Annual Summary
| Metric | FY2024 | FY2025 | TTM | YoY |
|---|---|---|---|---|
| Revenue | $58M | $70M | $77M | +22.2% |
| Gross Margin | 89.7% | 90.2% | 88.0% | +57bps |
| EBITDA | −$28M | −$30M | −$147M | -5.7% |
| EBITDA Margin | -48.9% | -42.3% | -39.4% | +660bps |
| Net Income | −$34M | −$35M | −$35M | -3.3% |
| Free Cash Flow | −$1M | $5M | −$28M | — |
| Net Cash | — | — | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- Gross Margin (TTM)88.0%
- EBITDA Margin (TTM)-39.4%
- Net Margin (TTM)-45.0%
- SBC / Revenue25.5%
The Company
Arteris licenses semiconductor system IP in three areas: network-on-chip interconnect products (FlexGen, FlexNoC, FlexWay, Ncore, CodaCache), SoC integration automation software (Magillem Registers, CSRCompiler, Magillem Connectivity), and hardware security verification software (Cycuity Radix-S, Radix-M, Radix-ST). The interconnect technology manages data movement across chiplets, single-die, and multi-die SoCs; FlexNoC and FlexWay have shipped since 2011, and the company estimates its solutions have been incorporated into over 4 billion production SoCs since inception.
Arteris is asset-light: it has no inventory, fabs, or packaging plants. It operates from leased offices in Campbell, California and Austin, Texas, about 15,500 square feet combined, plus leased space in France, Poland, China, Japan, Taiwan, and South Korea. As of March 31, 2026, it had 353 employees across eleven locations. Revenue comes from licensing/support/maintenance, variable royalties, and professional services/other.
Business Segments
Competitive Landscape
The 10-K names Arm and Cadence as competitors in interconnect and IP integration, with other smaller companies also competing. At the same time, Arm is also an expanding adopter of Arteris's Cycuity security technology, which the source flags as notable.
- ArmNamed in the 10-K as a competitor in interconnect/IP integration; also expanding adoption of Arteris Cycuity security technology across next-generation processors.
- CadenceNamed in the 10-K as a competitor in IP integration solutions; no further detail in the supplied source material.
Supply Chain
Arteris sits upstream of physical AI infrastructure: it licenses IP used inside chips, not in manufacturing. Documented relationships include Qualcomm, Arm, Cadence, Renesas, AMD, and Cycuity.
More on AIP: Earnings recap